African leaders to meet in Zambia to discuss country responses to HIV/AIDS

Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.

The article names "Mozambique's Joaquim Chissano, Tanzania's Benjamin Mkapa, Zambia's Kenneth Kaunda, former vice-president of Uganda Speciosa Wandira and Kenya's national AIDS control council chairperson, Miriam Were" as scheduled participants in the meetings, where leaders are expected to share how they are responding to HIV/AIDS in their respective countries.

National AIDS Council (NAC) spokesperson Justine Mwiinga "said during a media breakfast [last week] the champions would use the meeting to gain insight on progress and challenges towards the scaling up of HIV prevention initiatives in Zambia," according to the newspaper. Mwiinga "said the champions would further utilise the meeting to explore possible solutions to reduce new infections on HIV/AIDS."

Mwiinga "said in Lusaka [on Thursday] that current [NAC] chairperson, former Botswana president Festus Mogae would lead the delegation," the newspaper writes, noting that Zambia was selected for the site of the meeting "in order to encourage a renewed prevention drive towards a generation free of HIV/AIDS." The meeting will take place from October 19 through October 21 (10/1).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Affordability and supply remain critical to the success of long-lasting HIV drug